Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein

BMC Molecular Biology

Volumn 11, Issue , 2010, Pages

  Jul Larsen, Åsne ^a   Grudic, Amra ^a   Bjerkvig, Rolf ^a,b   Bøe, Stig O ^c,d  

^a UNIVERSITY OF BERGEN   (Norway)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; ISOPROTEIN; NUCLEAR PROTEIN; PML PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOSOME; HUMAN; HUMAN CELL; LYSOSOME; NUCLEAR LOCALIZATION SIGNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ACTIVE TRANSPORT; CELL NUCLEUS; CYTOPLASM; GENE EXPRESSION; GENETICS; METABOLISM; MUTATION; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; ENDOSOMES; GENE EXPRESSION; HUMANS; LYSOSOMES; MUTATION; NUCLEAR ENVELOPE; NUCLEAR PROTEINS; PROTEIN ISOFORMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 78449241862     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-11-89     Document Type: Article

References (43)

1. Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 2007, 8(12):1006-1016. 10.1038/nrm2277, 17928811.
2. Borden KL. Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Molecular and cellular biology 2002, 22(15):5259-5269. 10.1128/MCB.22.15.5259-5269.2002, 133952, 12101223.
3. Everett RD, Chelbi-Alix MK. PML and PML nuclear bodies: implications in antiviral defence. Biochimie 2007, 89(6-7):819-830. 10.1016/j.biochi.2007.01.004, 17343971.
4. Salomoni P. Stemming out of a new PML era?. Cell death and differentiation 2009, 16(8):1083-1092. 10.1038/cdd.2009.63, 19521423.
5. de The H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990, 347(6293):558-561. 10.1038/347558a0, 2170850.
6. Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VV, Dmitrovsky E, Evans RM. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991, 66(4):663-674. 10.1016/0092-8674(91)90112-C, 1652368.
7. Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 2005, 27(11):1147-1157. 10.1002/bies.20304, 16237670.
8. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, et al. The tripartite motif family identifies cell compartments. The EMBO journal 2001, 20(9):2140-2151. 10.1093/emboj/20.9.2140, 125245, 11331580.
9. Nisole S, Stoye JP, Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nature reviews 2005, 3(10):799-808. 10.1038/nrmicro1248, 16175175.
10. Uchil PD, Quinlan BD, Chan WT, Luna JM, Mothes W. TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS pathogens 2008, 4(2):e16. 10.1371/journal.ppat.0040016, 2222954, 18248090.
11. Campbell EM, Dodding MP, Yap MW, Wu X, Gallois-Montbrun S, Malim MH, Stoye JP, Hope TJ. TRIM5 alpha cytoplasmic bodies are highly dynamic structures. Molecular biology of the cell 2007, 18(6):2102-2111. 10.1091/mbc.E06-12-1075, 1877106, 17392513.
12. Maul GG, Everett RD. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. The Journal of general virology 1994, 75(Pt 6):1223-1233. 10.1099/0022-1317-75-6-1223, 8207389.
13. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss JF, Maul GG. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. The Journal of cell biology 1999, 147(2):221-234. 10.1083/jcb.147.2.221, 2174231, 10525530.
14. Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP. The mechanisms of PML-nuclear body formation. Molecular cell 2006, 24(3):331-339. 10.1016/j.molcel.2006.09.013, 1978182, 17081985.
15. Zhong S, Muller S, Ronchetti S, Freemont PS, Dejean A, Pandolfi PP. Role of SUMO-1-modified PML in nuclear body formation. Blood 2000, 95(9):2748-2752.
16. Fagioli M, Alcalay M, Pandolfi PP, Venturini L, Mencarelli A, Simeone A, Acampora D, Grignani F, Pelicci PG. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 1992, 7(6):1083-1091.
17. Jensen K, Shiels C, Freemont PS. PML protein isoforms and the RBCC/TRIM motif. Oncogene 2001, 20(49):7223-7233. 10.1038/sj.onc.1204765, 11704850.
18. Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG, Dejean A. Deconstructing PML-induced premature senescence. The EMBO journal 2002, 21(13):3358-3369. 10.1093/emboj/cdf341, 126090, 12093737.
19. Condemine W, Takahashi Y, Le Bras M, de The H. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells. Journal of cell science 2007, 120(Pt 18):3219-3227. 10.1242/jcs.007492, 17878236.
20. Hoppe A, Beech SJ, Dimmock J, Leppard KN. Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. Journal of virology 2006, 80(6):3042-3049. 10.1128/JVI.80.6.3042-3049.2006, 1395473, 16501113.
21. Xu ZX, Zou WX, Lin P, Chang KS. A role for PML3 in centrosome duplication and genome stability. Molecular cell 2005, 17(5):721-732. 10.1016/j.molcel.2005.02.014, 15749021.
22. Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN, Solomon E, de The H, Hay RT, Freemont PS. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. Journal of cell science 1999, 112(Pt 3):381-393.
23. Lin HK, Bergmann S, Pandolfi PP. Cytoplasmic PML function in TGF-beta signalling. Nature 2004, 431(7005):205-211. 10.1038/nature02783, 15356634.
24. McNally BA, Trgovcich J, Maul GG, Liu Y, Zheng P. A role for cytoplasmic PML in cellular resistance to viral infection. PloS one 2008, 3(5):e2277. 10.1371/journal.pone.0002277, 2386554, 18509536.
25. Henderson BR, Eleftheriou A. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Experimental cell research 2000, 256(1):213-224. 10.1006/excr.2000.4825, 10739668.
26. Leppard KN, Emmott E, Cortese MS, Rich T. Adenovirus type 5 E4 Orf3 protein targets promyelocytic leukaemia (PML) protein nuclear domains for disruption via a sequence in PML isoform II that is predicted as a protein interaction site by bioinformatic analysis. The Journal of general virology 2009, 90(Pt 1):95-104. 10.1099/vir.0.005512-0, 19088278.
27. Caceres JF, Misteli T, Screaton GR, Spector DL, Krainer AR. Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. The Journal of cell biology 1997, 138(2):225-238. 10.1083/jcb.138.2.225, 2138183, 9230067.
28. Hedley ML, Amrein H, Maniatis T. An amino acid sequence motif sufficient for subnuclear localization of an arginine/serine-rich splicing factor. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(25):11524-11528. 10.1073/pnas.92.25.11524, 40434, 8524796.
29. Li H, Bingham PM. Arginine/serine-rich domains of the su(wa) and tra RNA processing regulators target proteins to a subnuclear compartment implicated in splicing. Cell 1991, 67(2):335-342. 10.1016/0092-8674(91)90185-2, 1655279.
30. Jul-Larsen A, Grudic A, Bjerkvig R, Boe SO. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins. Journal of cell science 2009, 122(Pt 8):1201-1210. 10.1242/jcs.040840, 19339552.
31. Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, Orr A. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. Journal of virology 2006, 80(16):7995-8005. 10.1128/JVI.00734-06, 1563828, 16873256.
32. Ullman AJ, Hearing P. Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. Journal of virology 2008, 82(15):7325-7335. 10.1128/JVI.00723-08, 2493301, 18480450.
33. Shui W, Sheu L, Liu J, Smart B, Petzold CJ, Hsieh TY, Pitcher A, Keasling JD, Bertozzi CR. Membrane proteomics of phagosomes suggests a connection to autophagy. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(44):16952-16957. 10.1073/pnas.0809218105, 2579359, 18971338.
34. Condemine W, Takahashi Y, Zhu J, Puvion-Dutilleul F, Guegan S, Janin A, de The H. Characterization of endogenous human promyelocytic leukemia isoforms. Cancer research 2006, 66(12):6192-6198. 10.1158/0008-5472.CAN-05-3792, 16778193.
35. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature medicine 1997, 3(11):1271-1274. 10.1038/nm1197-1271, 9359704.
36. Henson JD, Neumann AA, Yeager TR, Reddel RR. Alternative lengthening of telomeres in mammalian cells. Oncogene 2002, 21(4):598-610. 10.1038/sj.onc.1205058, 11850785.
37. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer research 1999, 59(17):4175-4179.
38. Andrulis ED, Neiman AM, Zappulla DC, Sternglanz R. Perinuclear localization of chromatin facilitates transcriptional silencing. Nature 1998, 394(6693):592-595. 10.1038/29100, 9707122.
39. Fox MH, Arndt-Jovin DJ, Jovin TM, Baumann PH, Robert-Nicoud M. Spatial and temporal distribution of DNA replication sites localized by immunofluorescence and confocal microscopy in mouse fibroblasts. Journal of cell science 1991, 99(Pt 2):247-253.
40. Nagai S, Dubrana K, Tsai-Pflugfelder M, Davidson MB, Roberts TM, Brown GW, Varela E, Hediger F, Gasser SM, Krogan NJ. Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase. Science (New York, NY) 2008, 322(5901):597-602.
41. Lange A, Mills RE, Lange CJ, Stewart M, Devine SE, Corbett AH. Classical nuclear localization signals: definition, function, and interaction with importin alpha. The Journal of biological chemistry 2007, 282(8):5101-5105. 10.1074/jbc.R600026200, 17170104.
42. Gurrieri C, Nafa K, Merghoub T, Bernardi R, Capodieci P, Biondi A, Nimer S, Douer D, Cordon-Cardo C, Gallagher R, et al. Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia. Blood 2004, 103(6):2358-2362. 10.1182/blood-2003-07-2200, 14630830.
43. Jul-Larsen A, Visted T, Karlsen BO, Rinaldo CH, Bjerkvig R, Lonning PE, Boe SO. PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication. Experimental cell research 2004, 298(1):58-73. 10.1016/j.yexcr.2004.03.045, 15242762.